Global Perspectives on Gynecologic Malignancies at ESMO 2021

Expert perspectives and strategic insights on the latest therapeutic developments and translational research coming out of ESMO regarding gynecologic malignancies.

September 22, 2021

FACULTY CHAIR

Robert Coleman, MD

MD Anderson Cancer Center, Houston, TX, US

Faculty Members

Nicoletta Colombo, MD, PhD
European Institute of Oncology, Milan, Italy

Christina Fotopoulou, MD, PhD 
Imperial College London Healthcare Trust, London, UK

Jonathan Ledermann, MD
UCL Cancer Institute, London, UK

Mansoor Mirza, MD
Copenhagen University Hospital, Denmark

Ursula Matulonis, MD
Dana-Farber Cancer Institute, MA, US

David O’Malley, MD 
The Ohio State University College of Medicine, OH, US

Leslie M. Randall, MD 
UCI Health, CA, US

KEY TAKEAWAYS AND STRATEGIC INSIGHTS

  • First-Line Treatment and Maintenance Therapy for Advanced Ovarian Cancer 
  • Treatment Strategies for Relapsed Ovarian Cancer 
  • Current Treatment and Future Directions for Advanced Endometrial Cancer 
  • Advanced Cervical Cancer: Current and Future Treatment in First Line 
  • Recurrent Cervical Cancer: Current and Future Treatments 

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.